Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Apr. 30, 2022 $ 8,350 $ 81,555,379 $ (58,336,414) $ 23,227,315
Beginning balance, shares at Apr. 30, 2022 8,349,843      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,531 184,531
Net loss (1,945,358) (1,945,358)
Ending balance, value at Jul. 31, 2022 $ 8,350 81,747,312 (60,281,772) 21,473,890
Ending balance, shares at Jul. 31, 2022 8,349,843      
Beginning balance, value at Apr. 30, 2023 $ 9,296 84,799,263 (65,950,618) 18,857,941
Beginning balance, shares at Apr. 30, 2023 9,295,837      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,531 184,531
Net loss (2,894,683) (2,894,683)
Ending balance, value at Jul. 31, 2023 $ 9,296 $ 84,991,196 $ (68,845,301) $ 16,155,191
Ending balance, shares at Jul. 31, 2023 9,295,837